The Australian share market has experienced plenty of volatility in recent weeks, creating potential opportunities for savvy investors.
With April now underway and the market sinking deep into the red, there are some quality ASX shares that could be worth adding to your portfolio for the long term.
Here's a look at five of the best ASX shares to consider this month according to analysts.
Accent Group Ltd (ASX: AX1)
The footwear retailer behind brands such as Platypus, HypeDC, and The Athlete's Foot continues to perform well despite challenging retail conditions. Analysts at Bell Potter believe Accent Group's market leadership, store expansion, and growing private label strategy will drive solid earnings growth. The company also offers an attractive dividend yield.
Bell Potter has a buy rating and $2.75 price target on its shares.
CSL Ltd (ASX: CSL)
CSL is a global leader in biotechnology, specialising in blood plasma therapies and vaccines. With a strong track record of earnings growth and innovation, it remains one of the highest-quality companies on the local share market. Despite recent headwinds, its long-term outlook remains very positive.
It is for this reason that Bell Potter has a buy rating and $335.00 price target on its shares.
Lovisa Holdings Ltd (ASX: LOV)
The fashion jewellery retailer has been one of the ASX's best growth stories in recent years. With strong international expansion plans and a highly successful business model, Lovisa continues to be an ASX share with enormous promise. Its ability to scale rapidly while maintaining high margins could make it a compelling long-term investment.
Bell Potter is a fan and has a buy rating and $30.00 price target on its shares.
ResMed Inc (ASX: RMD)
Another ASX share to buy could be ResMed. It is a global leader in sleep apnoea treatment and respiratory care. With an ageing population and rising awareness of sleep disorders, demand for its products has been growing strongly.
Goldman Sachs expects this to continue and has put a conviction buy rating (its absolute highest rating) and $49.00 price target on its shares.
Xero Ltd (ASX: XRO)
Finally, Xero could be an ASX share to buy after the market selloff. It is a dominant force in cloud-based accounting software, particularly among small and medium-sized businesses. With a growing international presence and a strong subscription-based model, it has been a long-term winner for investors who believe in the shift to digital financial management.
Goldman Sachs believes that this can continue and has put a buy rating and $201.00 price target on its shares.
